Concurrent OX40 and CD30 Ligand Blockade Abrogates the CD4-Driven Autoimmunity Associated with CTLA4 and PD1 Blockade while Preserving Excellent Anti-CD8 Tumor Immunity. (2017)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.4049/jimmunol.1700088
PubMed Identifier: 28646041
Publication URI: http://europepmc.org/abstract/MED/28646041
Type: Journal Article/Review
Volume: 199
Parent Publication: Journal of immunology (Baltimore, Md. : 1950)
Issue: 3
ISSN: 0022-1767